{"id":13865,"date":"2019-12-05T17:16:00","date_gmt":"2019-12-05T17:16:00","guid":{"rendered":"http:\/\/eurojournalists.com\/?guid=d30d823a257154a4dac7030d9b21bba7"},"modified":"2019-12-05T17:16:00","modified_gmt":"2019-12-05T17:16:00","slug":"biogens-stock-rises-4-after-company-releases-new-data-on-late-stage-alzheimers-drug-cnbc","status":"publish","type":"post","link":"https:\/\/eurojournalists.com\/?p=13865","title":{"rendered":"Biogen’s stock rises 4% after company releases new data on late-stage Alzheimer’s drug – CNBC"},"content":{"rendered":"
    \n
  1. Biogen’s stock rises 4% after company releases new data on late-stage Alzheimer’s drug<\/a>  CNBC<\/font><\/li>\n
  2. New details emerge on drug that may slow Alzheimer’s disease<\/a>  NBCNews.com<\/font><\/li>\n
  3. Biogen Resumes Alzheimer\u2019s Studies to Offer Controversial Drug<\/a>  Bloomberg<\/font><\/li>\n
  4. Data on Biogen’s Alzheimer’s drug raise more questions than answers<\/a>  STAT<\/font><\/li>\n
  5. As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug<\/a>  Xconomy<\/font><\/li>\n
  6. View full coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Biogen’s stock rises 4% after company releases new data on late-stage Alzheimer’s drug  CNBCNew details emerge on drug that may slow Alzheimer’s disease  NBCNews.comBiogen Resumes Alzheimer\u2019s Studies to Offer Controversial Drug&nbsp…<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-13865","post","type-post","status-publish","format-standard","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/13865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13865"}],"version-history":[{"count":1,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/13865\/revisions"}],"predecessor-version":[{"id":13866,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/13865\/revisions\/13866"}],"wp:attachment":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}